Basic approaches to treatment of urinary tract infection in the practice of a family doctor

Abstract

The objective: a comparative study was aimed at the study of the effectiveness and evaluation of the dynamics of clinical and laboratory parameters of therapy with oral antimicrobial Flaprox versus nitrofuran therapy in patients with exacerbation of chronic urinary tract infection in outpatient settings.Materials and methods. Тhe study included 40 patients (16 men, 24 women) with exacerbation of chronic pyelonephritis. Participants in the study were divided into 2 groups: 26 patients who received Flaprox 500 mg twice a day for 10 days in the main group (A), 14 patients in the control group (B) received nitrofuran 100 mg 4 once a day for 10 days. The mean age of the patients was 39,8±8,9 years.Results. The regression of clinical manifestations of urinary tract infection in the study process was noted in both groups. In the main group, the dynamics of reduction of symptoms of general intoxication and normalization of local symptoms and inflammatory changes in blood and urine has a more pronounced tendency from 5 days of treatment and persisted throughout the course of therapy.Conclusions. Flaprox useing for 10 days allowed to reliably reduce or eliminate dysuria, infection of the urinary tract (bacteriuria), and inflammatory process (leukocythria) without negative changes in the blood biochemistry analysis. Therapy of UTI with Flaprox demonstrates efficacy in comparison with the use of nitrofurans and the achievement of positive dynamics of clinical and laboratory parameters in a shorter time.